RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 148 filers reported holding RELAY THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $35,017,760 | -33.0% | 4,163,824 | 0.0% | 1.18% | -7.8% |
| Q2 2023 | $52,297,629 | -23.7% | 4,163,824 | 0.0% | 1.28% | -42.0% |
| Q1 2023 | $68,578,181 | +10.2% | 4,163,824 | 0.0% | 2.21% | +16.6% |
| Q4 2022 | $62,207,531 | -33.2% | 4,163,824 | 0.0% | 1.89% | -31.1% |
| Q3 2022 | $93,145,000 | +49.3% | 4,163,824 | +11.8% | 2.75% | +27.7% |
| Q2 2022 | $62,369,000 | -9.1% | 3,723,541 | +62.5% | 2.15% | +0.4% |
| Q1 2022 | $68,583,000 | +25.5% | 2,291,441 | +28.8% | 2.14% | +23.2% |
| Q4 2021 | $54,636,000 | +25.1% | 1,779,084 | +28.4% | 1.74% | +14.5% |
| Q3 2021 | $43,678,000 | -73.4% | 1,385,276 | -69.1% | 1.52% | -75.2% |
| Q2 2021 | $164,208,000 | +38.5% | 4,487,776 | +30.9% | 6.14% | +16.7% |
| Q1 2021 | $118,553,000 | -10.9% | 3,429,363 | +7.1% | 5.26% | -26.5% |
| Q4 2020 | $133,019,000 | -2.4% | 3,200,649 | 0.0% | 7.15% | -26.4% |
| Q3 2020 | $136,316,000 | – | 3,200,649 | – | 9.72% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 4,068,574 | $68,149,000 | 5.76% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $467,408,000 | 3.71% |
| BVF INC/IL | 4,384,805 | $73,445,000 | 3.55% |
| Boxer Capital, LLC | 2,669,132 | $44,708,000 | 2.83% |
| Nextech Invest Ltd. | 475,485 | $7,964,000 | 2.69% |
| EcoR1 Capital, LLC | 3,723,541 | $62,369,000 | 2.15% |
| HARBOURVEST PARTNERS LLC | 296,402 | $4,965,000 | 1.63% |
| Integral Health Asset Management, LLC | 436,262 | $7,307,000 | 1.50% |
| Alphabet Inc. | 1,568,753 | $26,277,000 | 1.43% |
| Fernwood Investment Management, LLC | 185,063 | $3,100,000 | 1.34% |